3//SEC Filing
Lux Venture Partners IV, LLC 3
Accession 0001209191-21-026794
CIK 0001601830other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 2:18 PM ET
Size
15.8 KB
Accession
0001209191-21-026794
Insider Transaction Report
Form 3
Lux Ventures IV, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,825,883 underlying) - 12,501
Common Stock
- (indirect: See footnote)
Series A Preferred Stock
Exercise: $0.00→ Common Stock (10,279,275 underlying) - (indirect: See footnote)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (3,578,653 underlying) - (indirect: See footnote)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,490,783 underlying)
Lux Co-Invest Opportunities, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series A Preferred Stock
Exercise: $0.00→ Common Stock (10,279,275 underlying) - (indirect: See footnote)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,825,883 underlying) - (indirect: See footnote)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (3,578,653 underlying) - 12,501
Common Stock
- (indirect: See footnote)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,490,783 underlying)
Lux Co-Invest Partners, LLC
10% Owner
Holdings
- 12,501
Common Stock
- (indirect: See footnote)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,825,883 underlying) - (indirect: See footnote)
Series A Preferred Stock
Exercise: $0.00→ Common Stock (10,279,275 underlying) - (indirect: See footnote)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (3,578,653 underlying) - (indirect: See footnote)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,490,783 underlying)
Lux Venture Partners IV, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series B Preferred Stock
Exercise: $0.00→ Common Stock (3,578,653 underlying) - (indirect: See footnote)
Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,825,883 underlying) - (indirect: See footnote)
Series A Preferred Stock
Exercise: $0.00→ Common Stock (10,279,275 underlying) - (indirect: See footnote)
Series D Preferred Stock
Exercise: $0.00→ Common Stock (1,490,783 underlying) - 12,501
Common Stock
Footnotes (5)
- [F1]Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. Each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B Preferred Stock and Series D Preferred Stock shall automatically convert into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and has no expiration date. Each share of Series C Preferred Stock shall automatically convert into Common Stock on a 1.1869358:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and has no expiration date.
- [F2]Represents shares held of record by Lux Ventures IV, L.P.
- [F3]Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, or the Individual Managers. The Individual Managers, as the sole managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P. Each of Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, and the Individual Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.
- [F4]Represents shares held of record by Lux Co-Invest Opportunities, L.P.
- [F5]Represents 298,156 shares held of record by Lux Ventures IV, L.P. and 1,192,627 shares held of record by Lux Co-Invest Opportunities, L.P.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001633332
Filing Metadata
- Form type
- 3
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 2:18 PM ET
- Size
- 15.8 KB